MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition

Drug resistance is a significant obstacle when treating triple-negative breast cancer (TNBC). Several studies have demonstrated that microRNAs (miRNAs) have essential roles in regulating drug resistance in different types of cancer. miR-33a-5p has previously been reported to be a tumor suppressor in...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Xiaoqing, Gu, Shucheng, Yuan, Mu, Zheng, Xiangxin, Wu, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865640/
https://www.ncbi.nlm.nih.gov/pubmed/31788073
http://dx.doi.org/10.3892/ol.2019.10984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865640/
https://www.ncbi.nlm.nih.gov/pubmed/31788073
http://dx.doi.org/10.3892/ol.2019.10984

Ejemplares similares